ArticleJournal of Cancer2025

Elevated Serum IL-6 as a Negative Prognostic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Validation.

Sup Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.